未登录

J

Joana D. Amaral

Universidade de Lisboa

H指数:31

被引数:3,424

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Oliveira et al. Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology. Biomolecules 2020, 10, 945

更正：Oliveira等人. 与帕金森病病理生理学相关的循环炎性miRNA. Biomolecules 2020, 10, 945

IF4.8

2026-10-010

OA

Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors

钌 (II) 配合物作为线粒体干扰物诱导的坏死性凋亡

CELL DEATH DISCOVERY

IF7

2024-05-280

OAAI

A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-06-017

OAAI

Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-01-019

OAAI

Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-11-0123

OAAI

Harnessing Protein-Ligand Interaction Fingerprints to Predict New Scaffolds of RIPK1 Inhibitors

IF4.6

2022-07-233

OAAI

Oxidative stress and regulated cell death in Parkinson's disease

帕金森氏病中的氧化应激和调节性细胞死亡

AGEING RESEARCH REVIEWS

IF12.4

2021-05-01222

PREAI

Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-04-0140

PREAI

Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease

CELL DEATH & DISEASE

IF9.6

2019-11-0533

OAAI

A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation (vol 7, 15, 2019)

一种用于脑细胞分化的新型小分子p53稳定剂 (第7，15，2019卷)

FRONTIERS IN CHEMISTRY

IF4.2

2019-04-241

OAAI

A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation

一种新型脑细胞分化小分子p53稳定剂

FRONTIERS IN CHEMISTRY

IF4.2

2019-01-3110

OAAI

Mechanism and disease implications of necroptosis and neuronal inflammation

CELL DEATH & DISEASE

IF9.6

2018-09-0519

OAAI

Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammation

CELL DEATH DISCOVERY

IF7

2018-07-1023

OAAI

Spirotriazoline oxindoles: A novel chemical scaffold with in vitro anticancer properties

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2017-11-0126

PREAI

In vitro targeting of colon cancer cells using spiropyrazoline oxindoles

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2017-10-0134

PREAI

Activation of necroptosis in human and experimental cholestasis

CELL DEATH & DISEASE

IF9.6

2016-09-29109

OAAI

RIP3 REGULATES ACUTE CHOLESTASIS-ASSOCIATED NECROPTOTIC SIGNALING AND CELL DEATH

JOURNAL OF HEPATOLOGY

IF33

2016-01-010

PREAI

NECROPTOSIS CONTRIBUTES TO THE PATHOGENESIS OF CHOLESTATIC LIVER INJURY

JOURNAL OF HEPATOLOGY

IF33

2015-04-010

PREAI

Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset

NEUROBIOLOGY OF AGING

IF3.5

2015-01-01111

PREAI

Synthesis and evaluation of spiroisoxazoline oxindoles as anticancer agents

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2014-01-0159

PRE